Best General Drug Manufacturer Stocks to Buy Now (2025)Top general drug manufacturer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 1st ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GRFS | GRIFOLS SA | $9.75 | -0.81% | -1.02% | -7.84% | 9.92% | 20.37% | 9.55% | 17.90% | -41.55% | -41.90% | $11.14 | $6.19 | 12.48% | 57.51% | 0.76 | 908,000 | 24.73% |
| GSK | GSK PLC | $40.36 | 0.77% | -0.35% | 3.30% | 1.61% | 0.27% | -5.17% | 31.12% | -18.20% | -20.10% | $42.63 | $31.72 | 5.32% | 27.26% | 0.37 | 3,929,000 | 21.30% |
| BIIB | BIOGEN INC | $144.87 | 0.83% | 1.58% | 6.59% | 14.47% | 0.93% | -26.91% | -30.77% | -47.39% | -55.47% | $204.18 | $110.04 | 29.05% | 31.66% | 0.76 | 1,502,000 | -22.42% |
| LLY | ELI LILLY & CO | $760.13 | -0.60% | 0.73% | 8.89% | -3.93% | -7.84% | -16.12% | 149.15% | 398.54% | 744.78% | $939.86 | $623.78 | 19.12% | 21.86% | 0.60 | 3,471,000 | -10.56% |
| SNY | SANOFI | $46.97 | 0.23% | -0.40% | -5.76% | -2.59% | -20.28% | -17.47% | 15.72% | -9.79% | -7.65% | $60.12 | $44.73 | 21.87% | 5.01% | 0.35 | 3,020,000 | 71.01% |
| AMRN | AMARIN CORP PLC | $14.60 | -2.21% | -2.63% | -9.71% | 8.87% | 75.90% | 22.73% | -38.66% | -82.62% | -69.71% | $17.49 | $7.08 | 16.52% | 106.21% | 1.15 | 85,000 | 120.21% |
| NVS | NOVARTIS AG | $122.47 | -0.25% | -3.22% | -1.24% | 5.21% | 9.13% | 5.85% | 51.70% | 34.63% | 25.02% | $130.46 | $96.06 | 6.12% | 27.49% | 0.35 | 1,292,000 | 35.29% |
| GILD | GILEAD SCIENCES INC | $112.26 | 1.26% | -2.59% | -4.86% | 3.94% | 0.00% | 35.17% | 70.56% | 72.60% | 0.58% | $121.83 | $81.83 | 7.86% | 37.19% | 0.43 | 6,539,000 | 19.94% |
| AZN | ASTRAZENECA PLC | $77.69 | 0.17% | -3.86% | -1.81% | 9.47% | 0.41% | -1.07% | 33.97% | 38.88% | 129.78% | $82.41 | $61.24 | 5.73% | 26.86% | 0.44 | 4,659,000 | 36.67% |
| BMY | BRISTOL MYERS SQUIBB CO | $46.15 | -0.41% | -2.12% | -4.23% | -2.29% | -23.07% | -6.75% | -34.25% | -22.31% | -25.79% | $63.33 | $42.96 | 27.13% | 7.43% | 0.33 | 14,353,000 | 58.58% |
| ABBV | ABBVIE INC | $220.81 | 2.10% | 4.33% | 6.89% | 19.05% | 2.96% | 14.14% | 54.78% | 146.36% | 268.88% | $221.77 | $163.81 | 0.43% | 34.80% | 0.39 | 5,257,000 | 23.72% |
| JNJ | JOHNSON & JOHNSON | $177.20 | 0.42% | 0.80% | 0.54% | 16.29% | 8.82% | 6.06% | 6.57% | 20.40% | 86.84% | $181.16 | $140.68 | 2.19% | 25.96% | 0.24 | 6,715,000 | -15.64% |
| PFE | PFIZER INC | $24.05 | 0.63% | -2.12% | -4.07% | 0.21% | -7.68% | -19.38% | -47.07% | -34.68% | -28.17% | $30.43 | $20.92 | 20.97% | 14.99% | 0.41 | 46,311,000 | -18.69% |
| SCLX | SCILEX HOLDING CO | $24.96 | 10.64% | -1.83% | 28.79% | 437.93% | 137.71% | -31.43% | -93.11% | N/A | N/A | $39.90 | $3.60 | 37.44% | 593.33% | 0.40 | 275,000 | 4.17% |
| AMGN | AMGEN INC | $274.71 | 0.60% | -1.36% | -6.12% | -5.29% | -13.39% | -17.45% | 19.05% | 10.73% | 78.49% | $339.17 | $253.30 | 19.01% | 8.45% | 0.46 | 1,749,000 | -18.54% |
| MRK | MERCK & CO INC | $81.14 | 0.06% | -3.44% | -3.66% | 3.65% | -14.40% | -31.41% | -6.35% | -5.25% | 50.37% | $119.20 | $73.31 | 31.93% | 10.68% | 0.30 | 12,642,000 | 25.59% |
| OGN | ORGANON & CO | $10.45 | 0.87% | 1.85% | 12.61% | 6.09% | -33.10% | -49.15% | -63.07% | N/A | N/A | $20.48 | $8.01 | 48.97% | 30.46% | 0.80 | 5,393,000 | 45.95% |
| NSRX | NASUS PHARMA LTD | $8.13 | -0.06% | 1.69% | -5.41% | N/A | N/A | N/A | N/A | N/A | N/A | $9.99 | $7.51 | 18.67% | 8.15% | -0.72 | 22,700 | 886.96% |
| MIRA | MIRA PHARMACEUTICALS INC | $1.29 | -1.53% | -15.13% | -12.84% | 0.78% | 19.44% | -1.53% | N/A | N/A | N/A | $2.56 | $0.73 | 49.61% | 76.71% | 1.73 | 549,000 | -79.13% |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.